| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 24,125 | 23,992 | 23,639 | 25,353 | | Cost of Revenue | 6,448 | 7,634 | 8,099 | 8,364 | | | Gross Profit |
-
| 16,358 | 15,540 | 16,989 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,952 | 20,636 | 1,769 | 11,044 | | Non Recurring | 1,672 | (8,503) | 8,802 | 514 | | Others | 3,596 | 1,827 | 7,287 | 11,846 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 2,398 | (2,318) | (6,415) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,457 | 2,398 | (2,318) | (6,415) | | Interest Expense | (575) | 756 | 812 | 1,087 | | Income Before Tax | 1,698 | 1,642 | (3,130) | (7,502) | | Income Tax Expense | 560 | 490 | (1,096) | (2,758) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,138 | 1,152 | (2,034) | (4,744) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,138 | 1,152 | (2,034) | (4,744) | | Preferred Stock And Other Adjustments | (563) | (562) | (469) |
-
| | | Net Income Applicable To Common Shares | $575 | $590 | ($2,503) | ($4,744) |
|
0.01% Nasdaq 0.00%
Income Statement
